File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Id-1 promotes angiogenesis in hepatocellular carcinoma through HIF-1α-mediated VEGF upregulation
Title | Id-1 promotes angiogenesis in hepatocellular carcinoma through HIF-1α-mediated VEGF upregulation |
---|---|
Authors | |
Issue Date | 2006 |
Publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ |
Citation | The 97th Annual Meeting of the American Association of Cancer Research (AACR 2006), Washington, DC., 1-5 April 2006. In Cancer Research, 2006, v. 66 n. 8 suppl., p. 438, abstract no. 1860 How to Cite? |
Abstract | BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascularized tumor associated with poor prognosis. Angiogenesis plays a critical role in rapid growth and metastasis of HCC. Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors in HCC. A better understanding of the regulatory mechanisms of VEGF expression in HCC may reveal novel targets for treatment of this cancer. Recently, Id-1 (inhibitor of differentiation/DNA synthesis) has been suggested to play a role in cancer angiogenesis but the molecular mechanism remains unknown. Given the central role of VEGF in cancer angiogenesis, we performed a study to elucidate whether overexpression of Id-1 promotes angiogenesis in HCC by interacting with VEGF. METHODOLOGY: In this study, we examined the expression of Id-1 and its relationship with expression of VEGF in HCC by performing immunohistochemistry on HCC tissue microarray. The role of Id-1 in regulating angiogenesis in HCC was evaluated in vitro by ectopic Id-1 transfection, and the effect of inhibition of Id-1 expression on angiogenesis and tumor growth of HCC was studied in vitro and in vivo. RESULTS: Id-1over-expression correlated with HCC metastasis (p<0.001), and its expression significantly correlated with VEGF expression (p<0.001, r=0.47) by tissue microarray. Ectopic transfection of Id-1 into HCC cell lines induced VEGF secretion, and the culture medium of the Id-1 transfectants could induce morphological change and proliferation of human umbilical vein endothelial cells. Furthermore, the angiogenic effect of the culture medium of the Id-1 transfectants was reversed by treatment with an Flk-1 inhibitor, SU1498, or with a VEGF neutralizing antibody. Id-1 induced transcriptional activation of VEGF by upregulating its promoter harboring hypoxia inducible factor-1α (HIF-1α) binding site. Id-1 was able to increase HIF-1α protein but not mRNA expression. In hypoxic condition, Id-1 increased VEGF expression by stabilizing HIF-1α protein. By anti-sense approach, Id-1 downregulation led to suppression of HIF-1α-mediated VEGF production, and resulted in reduced tumor growth and vascularity when the HCC cells were injected subcutaneously in nude mice. CONCLUSION: Id-1 promoted angiogenesis in HCC through stabilization of HIF-1α protein and increased VEGF expression. Downregulation of Id-1 may be a novel target to inhibit angiogenesis in HCC. ©American Association for Cancer Research |
Description | Session - Tumor Biology 14: Tumor Angiogenesis and the Microenvironment 2: no. 1860 |
Persistent Identifier | http://hdl.handle.net/10722/95069 |
ISSN | 2023 Impact Factor: 12.5 2023 SCImago Journal Rankings: 3.468 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Poon, RTP | en_HK |
dc.contributor.author | Lee, TKW | en_HK |
dc.contributor.author | Yuen, APW | en_HK |
dc.contributor.author | Ling, MT | en_HK |
dc.contributor.author | Wang, XH | en_HK |
dc.contributor.author | Wong, YC | en_HK |
dc.contributor.author | Guan, XY | en_HK |
dc.contributor.author | Man, K | en_HK |
dc.contributor.author | Fan, ST | en_HK |
dc.date.accessioned | 2010-09-25T15:50:41Z | - |
dc.date.available | 2010-09-25T15:50:41Z | - |
dc.date.issued | 2006 | en_HK |
dc.identifier.citation | The 97th Annual Meeting of the American Association of Cancer Research (AACR 2006), Washington, DC., 1-5 April 2006. In Cancer Research, 2006, v. 66 n. 8 suppl., p. 438, abstract no. 1860 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | http://hdl.handle.net/10722/95069 | - |
dc.description | Session - Tumor Biology 14: Tumor Angiogenesis and the Microenvironment 2: no. 1860 | - |
dc.description.abstract | BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascularized tumor associated with poor prognosis. Angiogenesis plays a critical role in rapid growth and metastasis of HCC. Vascular endothelial growth factor (VEGF) is one of the most important angiogenic factors in HCC. A better understanding of the regulatory mechanisms of VEGF expression in HCC may reveal novel targets for treatment of this cancer. Recently, Id-1 (inhibitor of differentiation/DNA synthesis) has been suggested to play a role in cancer angiogenesis but the molecular mechanism remains unknown. Given the central role of VEGF in cancer angiogenesis, we performed a study to elucidate whether overexpression of Id-1 promotes angiogenesis in HCC by interacting with VEGF. METHODOLOGY: In this study, we examined the expression of Id-1 and its relationship with expression of VEGF in HCC by performing immunohistochemistry on HCC tissue microarray. The role of Id-1 in regulating angiogenesis in HCC was evaluated in vitro by ectopic Id-1 transfection, and the effect of inhibition of Id-1 expression on angiogenesis and tumor growth of HCC was studied in vitro and in vivo. RESULTS: Id-1over-expression correlated with HCC metastasis (p<0.001), and its expression significantly correlated with VEGF expression (p<0.001, r=0.47) by tissue microarray. Ectopic transfection of Id-1 into HCC cell lines induced VEGF secretion, and the culture medium of the Id-1 transfectants could induce morphological change and proliferation of human umbilical vein endothelial cells. Furthermore, the angiogenic effect of the culture medium of the Id-1 transfectants was reversed by treatment with an Flk-1 inhibitor, SU1498, or with a VEGF neutralizing antibody. Id-1 induced transcriptional activation of VEGF by upregulating its promoter harboring hypoxia inducible factor-1α (HIF-1α) binding site. Id-1 was able to increase HIF-1α protein but not mRNA expression. In hypoxic condition, Id-1 increased VEGF expression by stabilizing HIF-1α protein. By anti-sense approach, Id-1 downregulation led to suppression of HIF-1α-mediated VEGF production, and resulted in reduced tumor growth and vascularity when the HCC cells were injected subcutaneously in nude mice. CONCLUSION: Id-1 promoted angiogenesis in HCC through stabilization of HIF-1α protein and increased VEGF expression. Downregulation of Id-1 may be a novel target to inhibit angiogenesis in HCC. ©American Association for Cancer Research | - |
dc.language | eng | en_HK |
dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/ | - |
dc.relation.ispartof | Cancer Research | en_HK |
dc.title | Id-1 promotes angiogenesis in hepatocellular carcinoma through HIF-1α-mediated VEGF upregulation | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.email | Poon, RTP: poontp@hkucc.hku.hk | en_HK |
dc.identifier.email | Lee, TKW: tkwlee@hkucc.hku.hk | en_HK |
dc.identifier.email | Yuen, APW: pwyuen@hkucc.hku.hk | en_HK |
dc.identifier.email | Ling, MT: patling@HKUCC.hku.hk | en_HK |
dc.identifier.email | Wong, YC: ycwong@hkucc.hku.hk | en_HK |
dc.identifier.email | Guan, XY: xyguan@hkucc.hku.hk | en_HK |
dc.identifier.email | Man, K: kwanman@hkucc.hku.hk | en_HK |
dc.identifier.email | Fan, ST: stfan@hku.hk | en_HK |
dc.identifier.authority | Poon, RTP=rp00446 | en_HK |
dc.identifier.authority | Lee, TKW=rp00447 | en_HK |
dc.identifier.authority | Ling, MT=rp00449 | en_HK |
dc.identifier.authority | Wong, YC=rp00316 | en_HK |
dc.identifier.authority | Guan, XY=rp00454 | en_HK |
dc.identifier.authority | Man, K=rp00417 | en_HK |
dc.identifier.authority | Fan, ST=rp00355 | en_HK |
dc.identifier.hkuros | 118595 | en_HK |
dc.identifier.volume | 66 | - |
dc.identifier.issue | 8 suppl. | - |
dc.identifier.spage | 438, abstract no. 1860 | - |
dc.identifier.epage | 438, abstract no. 1860 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0008-5472 | - |